Mana.bio Funding & Investors

San Francisco, CA

Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.

Total Amount Raised: $29,500,000

Mana.bio's Investors

Andreessen Horowitz

Mana.bio Funding Rounds

Seed
$19,500,000
Oct 9, 2023
Seed Investors
Andreessen Horowitz
Base4 Capital
LionBird (ventures)
NFX
Technion
Seed
$5,000,000
Oct 6, 2022
Seed
$5,000,000
Oct 17, 2021
Seed Investors
NFX

Funding info provided by Diffbot.